The last few months have brought a flurry of MDR regulatory and  legislative activity, causing a morass of confusion. In this interview,  leading EU medtech lawyer Erik Vollebregt clarifies what the recent  spate of proposals and guidances mean for product companies and how they  should manage in these uncertain times, providing a look at what the  future looks like for medtech regulation in Europe.

View the latest issue of Market Pathways: https://bit.ly/3M4gsLc

View more podcast episodes: https://bit.ly/3vgFTlT

About Market Pathways   

Your premium guide to global medical device regulation, reimbursement  and  policy. Market Pathways delivers incomparable intelligence    exploring the people, challenges, and opportunities impacting the  global medtech regulatory and reimbursement community. View the latest issue of Market Pathways on MyStrategist.com